Agenus announces plans to conduct public offering of its common shares

Bookrunners Jefferies and William Blair, co-manager Oppenheimer assist

By Devika Patel

Knoxville, Tenn., May 20 – Agenus Inc. will price a public sale of common stock with a 30-day greenshoe, according to a preliminary prospectus supplement filed Wednesday with the Securities and Exchange Commission.

Jefferies and William Blair are the bookrunning managers and Oppenheimer & Co. is the co-manager.

Proceeds will be used for general corporate purposes, including working capital, capital expenditures, debt repayment or refinancing, research and development, clinical trials, acquisitions and investments.

Agenus is a Lexington, Mass., biotechnology company working to develop treatments for cancers and infectious diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.